Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now

UTSePress Research/Manakin Repository

Search UTSePress Research


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Bajorek, Beata en_US
dc.contributor.author Ren, Shu en_US
dc.contributor.editor en_US
dc.date.accessioned 2012-10-12T03:34:15Z
dc.date.available 2012-10-12T03:34:15Z
dc.date.issued 2012 en_US
dc.identifier 2011006088 en_US
dc.identifier.citation Bajorek Beata and Ren Shu 2012, 'Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now', Springer Science + Business Media B.V., vol. 34, pp. 88-97. en_US
dc.identifier.issn 2210-7703 en_US
dc.identifier.other C1 en_US
dc.identifier.uri http://hdl.handle.net/10453/18474
dc.description.abstract Objective Evidence from pivotal clinical trials conducted more than a decade ago supports the use of antithrombotic therapy, particularly warfarin, for stroke prevention in atrial fibrillation (AF). Despite the wide dissemination of this evidence since that time, there is anecdotal evidence that utilisation of therapy remains suboptimal, especially in the target elderly population, which is reflected in the development of practice tools such as the TAG Clinical Indicator ('Antithrombotics in AF' Indicator 1.6, 2007). Therefore, the objective of this study was to determine the current utilisation of antithrombotic therapy for elderly patients with AF in the local setting, and to compare this utilisation with the results of a prior audit (AUDIT 1), as well as against the recommendations of the TAG Clinical Indicator(TAG IND). en_US
dc.language en_US
dc.publisher Springer Science + Business Media B.V. en_US
dc.relation.isbasedon http://dx.doi.org/10.1007/s11096-011-9594-y en_US
dc.title Utilisation of antithrombotic therapy for stroke prevention in atrial fibrillation in a Sydney hospital: then and now en_US
dc.parent International Journal of Clinical Pharmacy en_US
dc.journal.volume 34 en_US
dc.journal.number en_US
dc.publocation Netherlands en_US
dc.identifier.startpage 88 en_US
dc.identifier.endpage 97 en_US
dc.cauo.name GSH.Pharmacy en_US
dc.conference Verified OK en_US
dc.for 111500 en_US
dc.personcode 112624 en_US
dc.personcode 0000082402 en_US
dc.percentage 100 en_US
dc.classification.name Pharmacology and Pharmaceutical Sciences en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
dc.description.keywords Drug therapy; Stroke; Cardiac arrhythmia; Pharmacology; Clinical outcomes en_US
dc.staffid en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record